Jyong Biotech Ltd. Ordinary Shares

NASDAQ:MENS

Biotechnology

Healthcare
$1.86 -1.41%

-$0.02 today

Market cap
$141.41M
Beta
2.08
P/E (TTM)
-25.1
EPS (TTM)
-$0.06
52W Low $1.43High $67.00

Volume 0.07M

Average 0.10M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$2.61M

FY 2025 · Annual

Net Income

-$4.67M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue121K122K127K120K100K
Gross Profit(121K)(122K)(127K)(120K)(100K)
Gross Margin—————
Research & Development1.56M1.29M1.07M927K731K
Selling, General & Admin845K1.54M1.73M1.13M1.78M
Operating Expenses2.4M2.83M2.8M2.06M2.51M
Depreciation & Amortization122K123K127K120K100K
EBITDA(3.24M)(5.74M)(3.52M)(1.86M)(2.51M)
EBITDA Margin—————
Operating Income(2.4M)(2.83M)(2.8M)(2.06M)(2.61M)
Operating Margin—————
Interest Income6K5K56K7K610K
Interest Expense835K765K757K1.04M2.54M
Other Income / Expenses(1.79M)(3.8M)(1.6M)(963K)(2.06M)
Income Before Tax(4.2M)(6.63M)(4.4M)(3.02M)(4.67M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(4.2M)(6.63M)(4.4M)(3.02M)(4.67M)
Net Margin—————
EPS (Basic)(0.06)(0.09)(0.06)(0.04)(0.06)
EPS (Diluted)(0.06)(0.09)(0.06)(0.04)(0.06)
Weighted Avg Shares76.03M76.03M76.03M76.03M73.01M
Weighted Avg Shares (Diluted)76.03M76.03M76.03M76.03M73.01M

MENS Earnings Waterfall · TTM

NASDAQ:MENS · Revenue to Net Income

Key Ratios

EPS$-0.09
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-142.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$4.7M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.09, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
20-F20-F filingMay 15, 2026
NT 20-FNT 20-F filingApr 29, 2026
SC 13DSC 13D filingApr 24, 2026
3Initial statement of beneficial ownershipApr 14, 2026
3Initial statement of beneficial ownershipApr 8, 2026

How much revenue does MENS generate?

Jyong Biotech Ltd. Ordinary Shares (MENS) reported $0.00 of revenue in fiscal 2025.

Is MENS profitable?

Jyong Biotech Ltd. Ordinary Shares (MENS) reported -$4.67M of net income.